The latest international news, analysis and features on the HIV epidemic from AVERT. Share your views and expertise with your peers in the comments box below the articles.
Young, sexually active women at high risk of HIV in South Africa more likely to take PrEP daily over other time or events-based methods new study finds.
PrEP for sex workers in South Africa can be a success for HIV prevention, as long as high levels of adherence are maintained.
Research from South Africa suggests a women’s HIV risk may be driven more by their male partner’s age rather than the age gap between them.
There is a high appetite for increased access to pre-exposure prophylaxis (PrEP) among gay app users in Switzerland, according to research looking into the need for a national PrEP programme.
Kenya embraces new HIV testing technologies to scale-up HIV prevention efforts in the country.
Most healthcare providers cite worries over risk compensation after providing PrEP, but experiences among doctors who do prescribe PrEP are positive.
Women’s views on voluntary male medical circumcision form an important part of the delivery and mass roll-out of this HIV prevention strategy.
The game-changing drug, Truvada – the only drug approved for PrEP – will be offered to groups considered at risk of HIV.
Despite a willingness of men to undergo voluntary medical male circumcision (VMMC) for HIV prevention benefits in sub-Saharan Africa, uptake is low with just 56% of the 20.8 million circumcisions by 2016 target met.
The European Commission has given pharmaceutical company, Gilead, the green light to market Truvada as pre-exposure prophylaxis (PrEP) across the region.